Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone

Am J Ophthalmol. 2007 Apr;143(4):701-4. doi: 10.1016/j.ajo.2006.10.045. Epub 2006 Nov 28.

Abstract

Purpose: To evaluate the efficacy and safety of photodynamic therapy (PDT) with verteporfin combined with intravitreal triamcinolone (TA) in retinal angiomatous proliferation (RAP).

Design: Retrospective, consecutive, noncomparative case series.

Methods: Patients newly diagnosed with RAP underwent indocyanine green angiography (ICGA)-guided PDT with verteporfin, immediately followed by intravitreal TA. Complete ocular examination, fluorescein angiography (FA), ICGA, and optical coherence tomography (OCT) were performed at baseline and follow-up visits every three months.

Results: Seventeen eyes of seventeen patients underwent this simultaneous combined treatment. All patients had 12 months of follow-up. Complete resolution of angiographic leakage was achieved in 83% at 12 months. Visual acuity improved in 35%, and was stable in 47%. Eleven patients developed recurrent leakage after six to 12 months, which settled completely after repeat combined treatment.

Conclusions: This simultaneous combined treatment in patients with RAP was effective in reducing or eliminating retinal edema, regression of neovascularization, and stabilizing or improving visual acuity.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiomatosis / drug therapy*
  • Coloring Agents
  • Drug Therapy, Combination
  • Female
  • Fluorescein Angiography
  • Follow-Up Studies
  • Glucocorticoids / therapeutic use*
  • Humans
  • Indocyanine Green
  • Injections
  • Macular Degeneration / drug therapy*
  • Male
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use
  • Porphyrins / therapeutic use
  • Retinal Neovascularization / drug therapy*
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Triamcinolone Acetonide / therapeutic use*
  • Verteporfin
  • Visual Acuity / physiology*
  • Vitreous Body

Substances

  • Coloring Agents
  • Glucocorticoids
  • Photosensitizing Agents
  • Porphyrins
  • Verteporfin
  • Triamcinolone Acetonide
  • Indocyanine Green